Publicaciones en las que colabora con MIGUEL PAYA PERIS (51)

2006

  1. Marine sponge metabolites for the control of inflammatory diseases

    Current Opinion in Investigational Drugs, Vol. 7, Núm. 11, pp. 974-979

2005

  1. Búsqueda y evaluación de nuevos agentes naturales con actividad antiinflamatoria y antiartrítica

    Revista de fitoterapia, Vol. 5, Núm. 1, pp. 82

  2. Protection against 2,4,6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongiolide M

    Biochemical Pharmacology, Vol. 69, Núm. 10, pp. 1433-1440

2004

  1. Histamina y fármacos antihistamínicos. Farmacología de otros mediadores inflamatorios

    Velázquez. Farmacología Básica y Clínica (Editorial Médica Panamericana S.A.), pp. 487-500

2003

  1. Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-α by inhibiting nuclear factor-κB activation

    British Journal of Pharmacology, Vol. 138, Núm. 8, pp. 1571-1579

  2. Inhibition of the NF-κB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M

    Biochemical Pharmacology, Vol. 65, Núm. 5, pp. 887-895

2001

  1. Inhibition of acute and chronic inflammatory responses by the hydroxybenzoquinonic derivative rapanone

    Planta Medica, Vol. 67, Núm. 9, pp. 791-795

2000

  1. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 361, Núm. 1, pp. 98-106

  2. New pyridinium alkaloids from a marine sponge of the genus Spongia with a human phospholipase A2 inhibitor profile

    Journal of Natural Products, Vol. 63, Núm. 3, pp. 322-326

1999

  1. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation

    Journal of Pharmacology and Experimental Therapeutics, Vol. 289, Núm. 1, pp. 166-172

  2. Manoalide

    Current Medicinal Chemistry, Vol. 6, Núm. 5, pp. 415-431

  3. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2

    British Journal of Pharmacology, Vol. 126, Núm. 1, pp. 301-311

1998

  1. A new cacospongionolide inhibitor of human secretory phospholipase A2 from the tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides

    Journal of Natural Products, Vol. 61, Núm. 7, pp. 931-935

  2. Anti-inflammatory activity in mice of extracts from Mediterranean marine invertebrates

    Life Sciences, Vol. 62, Núm. 9

  3. Petrosaspongiolides M-R: New potent and selective phospholipase A2 inhibitors from the new Caledonian marine sponge Petrosaspongia nigra

    Journal of Natural Products, Vol. 61, Núm. 5, pp. 571-575

  4. Suppression of leukotriene B4 and tumour necrosis factor α release in acute inflammatory responses by novel prenylated hydroquinone derivatives

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 357, Núm. 5, pp. 565-572

  5. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues

    Journal of Medicinal Chemistry, Vol. 41, Núm. 17, pp. 3232-3238

1997

  1. Erratum: Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity (Biochemical Pharmacology (1997) 53 (733-740))

    Biochemical Pharmacology

  2. Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity

    Biochemical Pharmacology, Vol. 53, Núm. 5, pp. 733-740

  3. Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch

    British Journal of Pharmacology, Vol. 120, Núm. 8, pp. 1445-1452